Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
Who would have thought that medical education could help bridge the divide between Israelis, Jordanians, and Palestinians? As CISEPO (Canada International Scientific Exchange Program), a Canadian-registered, nongovernmental organization, has...
As of late August, the Senate Committee on Finance had finished collecting an initial set of responses from pharmaceutical companies concerning educational grants but had not yet begun reviewing the responses; nor did it have a set timeline for...
Attention medical meeting and CME planners! It's budgeting season at pharmaceutical companies right now. This is the one time of year that medical marketers put aside their product promotions, sales meetings, and advertising schedules to...
Germany and Sweden have issued codes of conduct for relationships between CME providers, physicians, and pharmaceutical companies, announced speakers at the Tenth Annual Meeting of the Global Alliance for Medical Education, held June 19 to 21 at...
I manage the education for an association that has 180 courses, 35 symposia presentations, 510 paper presentations, more than 500 poster exhibits, and 80 scientific exhibits. As you can imagine, this adds up to thousands of authors, presenters...
THIS YEAR'S HEALTHCARE Convention & Exhibitors Association Annual Meeting, held June 4 to 7 in New Orleans, boasted a whopping 70 increase in educational sessions, focusing on the latest developments in exhibit management. Since it's important...
Imagine if doctors could find and eliminate cancer cells before a tumor develops, implant a pump the size of a molecule to deliver medication exactly where it is needed in a patient's body, or remove the broken part of a cell and replace it with a...
The typical approach to controlling meeting costs in pharmaceutical companies is to do so externally — that is, to manage expenses through relationships with suppliers and by negotiating. But Bristol-Myers Squibb Co. has taken an unusual and...
Mark your calendars: Medical Meetings and the Center for Business Intelligence are currently planning the Second Annual Pharmaceutical Meeting Planners Forum, scheduled for March 2006 in Philadelphia. The program will include several session...
SINCE MAY 1, PEOPLE in CME Land have been talking about the implementation of the updated Standards for Commercial Support, particularly the resolution of conflicts of interest (COI). Asking course directors, instructors, planners, and CME...
